Prostate Cancer News

 
 
  • Gardening May Help Cancer Survivors Eat Better, Feel Greater ‘Worth’ For cancer survivors, three seasons of home vegetable gardening may increase physical activity, fruits and vegetables in the diet and also enhance feelings of self-worth, researchers say.
  • Polygenic Score Predicts Age of Onset of Aggressive Prostate Cancer A new polygenic score can be used to predict an individual man's age of onset of aggressive prostate cancer - and thereby guide screening efforts - according to findings from the PRACTICAL Consortium.
  • U.S. Court Invalidates Patent on J&J Cancer Drug Zytiga A U.S. administrative court on Wednesday invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions.
  • Google Venture Arm Backs UK Universal Flu Vaccine Company A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds ($27 million) from investors including GV, the venture capital arm of Google parent Alphabet Inc.
  • Biopsies Often Not Useful 2 Years After Radiotherapy for Prostate Cancer Two-year post-radiotherapy biopsies do not predict survival for most men with prostate cancer, according to results from the RT01 trial.
  • This Gene Test Might Guide PSA Screening: Two Views A new gene test may offer a way to identify men who would benefit from prostate-specific antigen (PSA) screening for prostate cancer, say investigators. But an expert is not convinced at this time.
  • Hot Flashes Caused by Cancer Therapy Can Be Prevented, Treated Cancer patients with hot flashes related to hormone therapy should know that these uncomfortable symptoms can be managed, according to a recently published resource for patients.
  • Cancer Death Rates Continue to Fall in US -- Why? Cancer-related mortality rates continue to decline across the United States, with some of the largest decreases seen in lung cancer among men between 1990 and 2015.
  • For Five Cancers, Screening Skews Risk Factors Cancer risk factors are typically based on characteristics at the time of diagnosis. In a new essay, a pair of major figures on the US cancer scene explain why that is a problem when cancers are detected by testing.
  • Epidemic of Screening Burdens Nation's Older Patients Screening in the nation's oldest patients is highly unlikely to detect lethal disease, hugely expensive and more likely to harm than help. And yet such screening is epidemic in the United States.
  • Teen Acne Tied to Prostate Cancer Risk Swedish researchers report an association between acne -- particularly severe acne -- in the late teen years and later prostate cancer risk, a finding that validates other research.
  • France's Sanofi Pins Hopes on New Drugs After Setbacks French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.
  • Living in Very Cold Climate and Increased Cancer Risk A study demonstrating the environmental impact on natural selection of genetic variants for survival supports a 'long-standing' hypothesis about the origins of cancer.
  • RSNA New Prostate Cancer Imaging Tracer Improves Detection 18F-PSMA-1007, an emerging agent for prostate imaging, can improve the detection of lesions and the targeting of radiotherapy, new research shows.
  • Concern Over Adverse Events in Prostate Cancer Trial A phase 3 trial investigating the addition of radium-223 to abiraterone acetate plus steroid has been stopped after reports of fractures and deaths.
  • When PSA Is 4-10, phi Test Helps With Biopsy Decision For men whose PSA level is 4-10 ng/mL, the decision to perform a biopsy is tough, because most will not reveal a cancer. The Prostate Health Index (phi) test may help clinicians with the process.
  • Lotus Valve Hits New Snag, Delaying Rollout Plans Lotus valves were recalled worldwide earlier this year because of problems with its delivery system but a new concern has been identified in final design testing.
  • Yearly Biopsy Not Needed for Prostate Cancer Surveillance Men with prostate cancer on active surveillance can undergo a biopsy once every 2 years instead of annually, concludes a new analysis of four major cohort studies.
  • Brits Up Cancer Screening With Mobile Lung CT Units England is upping cancer screening with mobile lung screening units in parking lots, as well as home-based tests for colorectal cancer and MRI for prostate cancer diagnosis.
  • Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure Whole pelvic radiation therapy (WPRT) and androgen deprivation therapy (ADT) reduce the risk of biochemical failure in men who receive post-prostatectomy salvage radiotherapy for prostate cancer, according to a database study.